A distinct classification of myeloid and lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, FGFR1 or with a PCM1-JAK2 rearrangement is described in the WHO 2017 [1]. The gene discussed is PDGFRB; the disease is Increased total eosinophil count.